Elliot Tapper
@ebtapper
Hepatologist @michiganliver @vaannarbor; #cirrhosis; encephalopathy; frailty; quality improvement; father; husband. #livertwitter Co-EIC of @HepCommJournal
ID:371895528
https://www.uofmhealth.org/profile/4313/elliot-benjamin-tapper-md 11-09-2011 18:32:59
11,3K Tweets
37,6K Followers
779 Following
Follow People
✅ out this 💥 Review from Hepatology Communications‼️
📑 Learn about current and emerging tools for #HCC surveillance🔎! 🧵
#LiverTwitter #OncTwitter #OpenAccess
journals.lww.com/hepcomm/Fullte…
The fatty liver index should be used with caution in liver research, particularly when studying “Lean MASLD/NAFLD” where it is just measuring GGT and triglycerides doi.org/10.1097/hep.00… HEPATOLOGY Journal
this question …
“Have you delayed getting care in the past 12 months because you did not have transportation?”
… is one of the most important we can ask
Nneka N. Ufere, MD MSCE on transportation insecurity journals.lww.com/hepcomm/fullte…
#livertwitter Marina Serper, MD, MS
The safety and efficacy of biologic therapy among people with primary sclerosing cholangitis and IBD
👍endoscopic response
😢no improvement in cholestasis
🧐⬆️ enzymes on vedo?
Open access: journals.lww.com/hepcomm/fullte… #gitwitter #livertwitter
First author: Dr Ayesha Shah
Tip: a normal ALT level does not exclude advanced liver disease
Especially true in hepatitis B
New study open access in Hepatology Communications journals.lww.com/hepcomm/fullte… #livertwitter #MedTwitter
So proud of this work done by Mayo Clinic Internal Medicine Residency Rochester super 🌟Nick Smith MD
Honored I get to mentor w/ my dear friend and Mayo Clinic Gastroenterology & Hepatology phenomenal PD Doug Simonetto, MD
Take home:
➡️lactate> 2 = high risk of mortality
➡️ MAP > 65 in the first 24hs = better outcomes in cirrhosis
#liverICU
🆕 Study on ICU septic shock patients w/wo #cirrhosis :
🔑 No significant difference in mortality or need for renal replacement therapy when comparing initial serum lactate & MAP targets
💉 Similar responses to treatment in both groups
🚨 For cirrhosis patients, high admission…
1) Criteria for steatotic liver disease applicable?
2) Do subclasses make clinical sense with distinct prognoses?
3) Should we establish criteria for historical alcohol intake?
YES, YES and YES!
Just published in The Lancet Gastroenterology & Hepatology
Full paper thelancet.com/journals/langa…
Summary👇